Development and validation of a prognostic nomogram for Hurthle cell thyroid carcinoma: a SEER-based study

被引:3
作者
Shen, Cong [1 ]
Zhao, Yunzhe [1 ]
Qiu, Xiangyuan [1 ]
Li, Peng [1 ]
Ding, Ying [1 ]
Wang, Wenlong [1 ]
Sun, Botao [1 ]
Li, Xinying [1 ,2 ]
Jiang, Wei [1 ,2 ]
机构
[1] Cent South Univ, Xiangya Hosp, Dept Gen Surg, Changsha 410008, Peoples R China
[2] Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha, Peoples R China
基金
中国国家自然科学基金;
关键词
Hurthle cell carcinoma; nomogram; overall survival; cancer-specific survival; SEER database; RADIOACTIVE IODINE; CANCER; SURVIVAL; DIAGNOSIS;
D O I
10.21037/gs-21-781
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Hurthle cell carcinoma is a rare subtype of thyroid cancer, and its clinical behavior and biological characteristics remain unclear. This study aimed to establish nomogram models for the prognostic evaluation of Hurthle cell thyroid carcinoma (HCTC) in terms of both cancer-specific survival (CSS) and overall survival (OS). Methods: Data for a total of 3,264 patients with HCTC (2004 to 2018) were extracted from the Surveillance, Epidemiology, and End Results (SEER) database. Univariate and multivariate Cox regression analysis was performed to identify significant predictors of prognosis and develop a prognostic nomogram. The performance of the model was assessed based on the area under the receiver operating characteristic curve (AUC), concordance index (c-index), and calibration curves. Results: Multivariate Cox regression analysis showed that age, sex, summary stage, tumor size, N stage, M stage, and treatment with thyroidectomy were independent predictors of OS. Moreover, age, summary stage, tumor size, N stage, M stage, AJCC stage, and treatment with thyroidectomy were significantly correlated with CSS. The c-index of the OS and CSS nomograms developed based on these factors was 0.822 (95% CI: 0.803-0.841) and 0.893 (95% CI: 0.866-0.920), respectively. The AUC was 0.888, 0.841, and 0.834 for 1-, 3-, and 5-year OS and 0.970, 0.949, and 0.933 for 1-, 3-, and 5-year CSS, respectively. The calibration curves showed good agreement between observed and predicted values. Moreover, decision curve analysis revealed that the nomogram had a better clinical utility than individual clinicopathological markers. Conclusions: A prognostic nomogram that allows the individualized assessment of OS and CSS in HCTC was developed. This nomogram could be used to guide treatment decisions in patients with HCTC.
引用
收藏
页码:535 / 544
页数:10
相关论文
共 31 条
[1]   Hurthle cell carcinoma: current perspectives [J].
Ahmadi, Sara ;
Stang, Michael ;
Jiang, Xiaoyin Sara ;
Sosa, Julie Ann .
ONCOTARGETS AND THERAPY, 2016, 9 :6873-6884
[2]   The role of radioactive iodine in the treatment of Hurthle cell carcinoma of the thyroid [J].
Besic, N ;
Vidergar-Kralj, B ;
Frkovic-Grazio, S ;
Movrin-Stanovnik, T ;
Auersperg, M .
THYROID, 2003, 13 (06) :577-584
[3]   Survival and prognosis in Hurthle cell carcinoma of the thyroid gland [J].
Bhattacharyya, N .
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2003, 129 (02) :207-210
[4]   Thyroid cancer [J].
Cabanillas, Maria E. ;
McFadden, David G. ;
Durante, Cosimo .
LANCET, 2016, 388 (10061) :2783-2795
[5]   Clinical and Molecular Features of Hurthle Cell Carcinoma of the Thyroid [J].
Chindris, Ana-Maria ;
Casler, John D. ;
Bernet, Victor J. ;
Rivera, Michael ;
Thomas, Colleen ;
Kachergus, Jennifer M. ;
Necela, Brian M. ;
Hay, Ian D. ;
Westphal, Sydney A. ;
Grant, Clive S. ;
Thompson, Geoffrey B. ;
Schlinkert, Richard T. ;
Thompson, E. Aubrey ;
Smallridge, Robert C. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (01) :55-62
[6]   Deep learning radiomic nomogram can predict the number of lymph node metastasis in locally advanced gastric cancer: an international multicenter study [J].
Dong, D. ;
Fang, M. -J. ;
Tang, L. ;
Shan, X. -H. ;
Gao, J. -B. ;
Giganti, F. ;
Wang, R. -P. ;
Chen, X. ;
Wang, X. -X. ;
Palumbo, D. ;
Fu, J. ;
Li, W. -C. ;
Li, J. ;
Zhong, L. -Z. ;
De Cobelli, F. ;
Ji, J. -F. ;
Liu, Z. -Y. ;
Tian, J. .
ANNALS OF ONCOLOGY, 2020, 31 (07) :912-920
[7]   Comparison of clinical characteristics of patients with follicular thyroid carcinoma and Hurthle cell carcinoma [J].
Ernaga Lorea, Ander ;
Migueliz Bermejo, Iranzu ;
Anda Apinaniz, Emma ;
Pineda Arribas, Javier ;
Toni Garcia, Marta ;
Martinez de Esteban, Juan Pablo ;
Insausti Serrano, Ana Maria .
ENDOCRINOLOGIA DIABETES Y NUTRICION, 2018, 65 (03) :136-142
[8]   Genomic Dissection of Hurthle Cell Carcinoma Reveals a Unique Class of Thyroid Malignancy [J].
Ganly, Ian ;
Ricarte Filho, Julio ;
Eng, Stephanie ;
Ghossein, Ronald ;
Morris, Luc G. T. ;
Liang, Yupu ;
Socci, Nicholas ;
Kannan, Kasthuri ;
Mo, Qianxing ;
Fagin, James A. ;
Chan, Timothy A. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (05) :E962-E972
[9]   Hurthle Cell Carcinoma A Population-Level Analysis of 3311 Patients [J].
Goffredo, Paolo ;
Roman, Sanziana A. ;
Sosa, Julie A. .
CANCER, 2013, 119 (03) :504-511
[10]   Follicular thyroid cancer and Hurthle cell carcinoma: challenges in diagnosis, treatment, and clinical management [J].
Grani, Giorgio ;
Lamartina, Livia ;
Durante, Cosimo ;
Filetti, Sebastiano ;
Cooper, David S. .
LANCET DIABETES & ENDOCRINOLOGY, 2018, 6 (06) :500-514